Toronto stocks closed one percent higher on Tuesday, but trailed a stronger rally in New York as fears of a U.S. interest rate hike eased on weak U.S. inflation numbers.
The Toronto Stock Exchange's key 300 Composite Index soared 64.22 points, or 1.1 percent, to close at 5743.55. On Monday, the index was down more than 10 percent since setting its lifetime high of 6348 points on March 11.
The Dow Jones Industrial Average surged 135.26 points to close at 6587.16.
Toronto's gains were restrained by its heavyweight gold group, which dropped two percent on weak gold prices.
"We're just following the U.S. side. The U.S. side is very strong on consumer price index numbers," said Montreal-based analyst Bill Ram.
The U.S. Labor Department said on Tuesday the consumer price index rose 0.1 percent in March. Economists surveyed by Reuters had forecast a gain of 0.2 percent.
The weaker numbers inspired investors to put aside fears of another U.S. rate move -- at least for a while, Ram said.
Turnover was moderate with volume of 77.1 million shares worth C$1.35 billion ($966 million).
Of Toronto's 14 sub-indices, 11 rose led by banks, conglomerates and utilities. On the weak side, gold fell two percent followed by moderate losses in consumer products and real estate.
Advancing stocks outpaced declining issues 513 to 416 with 299 unchanged.
Among hot stocks, Bre-X Minerals Ltd. dropped 0.22 to 2.23 on 5.3 million shares, topping the most-active list.
Bank of Nova Scotia jumped 1.45 to 50.15, while the Toronto Dominion Bank rose 1.40 to 37.00.
Conglomerate BCE Inc., Canada's largest publicly traded company, added 2.10 to finish at 63.70 on 1.2 million shares.
Biotechnology firm BioChem Pharma Inc. lost 5.60 to 26.40 as the market appeared to react coolly to clinical trial results released last week on its Hepatitis B drug, lamivudine.
